Regorafenib and PD-1 Antibody in Combination With Radiotherapy for pMMR/MSS Metastatic Colorectal Cancer

NCT04030260 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Cancer Metastatic
MSS

Interventions

DRUG: Regorafenib and PD-1 antibody in Combination with Radiotherapy
RADIATION: Radiation therapy

Sponsor

Sun Yat-sen University